Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

Exclusion criteria

• ✕. History of active inflammatory bowel disease within the last six months;
• ✕. Major gastrointestinal tract surgery such as gastrectomy, gastroenterostomy, or bowel resection;
• ✕. Gastro-intestinal ulcers and/or gastrointestinal or rectal bleeding within last six months;
• ✕. Pancreatic injury or pancreatitis within the last six months;